PharmaShots | Incisive News in 3 Shots

Subscribe Now

mainland China

I-Mab Entered into a Collaboration with Jumpcan to Develop and Commercialize Eftansomatropin Alfa (TJ101) in Mainland China

I-Mab Entered into a Collaboration with Jumpcan to Develop and Commercialize Eftansomatropin Alfa (TJ101) in Mainland China

November 11, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us